[ARS] Genelux Corporation SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

07/11/2025 - 08:10 AM

ARS - Genelux Corporation

ARS Filing - Genelux Corporation

This filing is available as a PDF document.

Filing Type: ARS

Company: Genelux Corporation (GNLX)

Acceptance Date: 2025-07-11T08:10:38.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Genelux Corp

NASDAQ:GNLX

GNLX Rankings

#4921 Ranked by Market Cap

N/A Ranked by Dividends

GNLX Latest News

Feb 18, 2026

Genelux Corporation to Participate in Upcoming Conferences

Jan 12, 2026

Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners

Jan 8, 2026

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

Jan 7, 2026

Genelux Corporation Announces Proposed Public Offering of Common Stock

Jan 5, 2026

Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

GNLX Latest SEC Filings

Feb 17, 2026

[SCHEDULE 13G/A] GENELUX Corp Amended Passive Investment Disclosure

Feb 2, 2026

[8-K] GENELUX Corp Reports Material Event

Jan 8, 2026

[424B5] GENELUX Corp Prospectus Supplement (Debt Securities)

Jan 7, 2026

[424B5] GENELUX Corp Prospectus Supplement (Debt Securities)

Jan 7, 2026

[Form 3] GENELUX Corp Initial Statement of Beneficial Ownership

GNLX Stock Data

Market Cap 117.16M

Float 39.85M

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City WESTLAKE VILLAGE